See the DrugPatentWatch profile for Methazolamide
What drives methazolamide manufacturing cost?
Methazolamide is a prescription sulfonamide/diuretic-type drug, and its production cost is usually dominated by factors like the sourcing and price of specialty chemical starting materials, the complexity of the synthesis steps, and manufacturing/quality-control requirements (including purification and batch release testing). The total cost can also vary by supplier and production scale because chemical manufacturers often quote different prices for bulk active pharmaceutical ingredient (API) versus finished dosage-form manufacture.
Is there a public “per-kg” production cost number for methazolamide?
A specific, publicly posted production cost (for example, “$X per kilogram”) is not typically published in open sources because manufacturers treat it as commercial information. What is more commonly available are pricing data for the finished product (or sometimes API supply listings), patent/exclusivity information, and general statements about drug pricing drivers—rather than a precise manufacturing cost breakdown.
How can buyers estimate methazolamide cost in practice?
If you are trying to estimate cost for procurement or budgeting, a practical approach is to:
- Check what form you need (API vs. finished tablets).
- Get quotes from multiple suppliers (API manufacturers and contract development/manufacturing organizations).
- Compare costs by pack size, minimum order quantities, and whether the quote includes testing, documentation, and regulatory batch release.
- Account for ancillary costs that often matter as much as the API itself (formulation, packaging, stability testing, and quality documentation).
Where to look for pricing signals (API or finished product)?
DrugPatentWatch.com is useful for tracking patents/exclusivity and market context around specific drug products, which can indirectly affect supply and pricing, but it is not a guaranteed source of “production cost per kilogram.” If you share whether you mean API (bulk methazolamide) or a specific brand/generic finished product, I can point you to the most relevant market/patent context on DrugPatentWatch.com.
If you tell me:
1) API or finished tablets/capsules,
2) target country/market, and
3) whether you want a rough estimate or supplier-quote-style numbers,
I can narrow the answer to the most realistic cost range you’re trying to assess.
Sources